Gotowa bibliografia na temat „Bisphosphonate”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Bisphosphonate”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Bisphosphonate"
Bergner, R. "Bisphosphonattherapie bei renaler Osteopathie". Osteologie 17, nr 03 (2008): 154–58. http://dx.doi.org/10.1055/s-0037-1619862.
Pełny tekst źródłaAnghelescu, Doralina L., Varayini Pankayatselvan, Rosa Nguyen, Deborah Ward, Jianrong Wu, Huiyun Wu, Denaya D. Edwards i Wayne Furman. "Bisphosphonate Use in Pediatric Oncology for Pain Management". American Journal of Hospice and Palliative Medicine® 36, nr 2 (16.08.2018): 138–42. http://dx.doi.org/10.1177/1049909118793114.
Pełny tekst źródłaKlotz, Christopher, Franz Jakob, Matthias Kohl, Simon von Stengel, Uwe Lange, Friederike Thomasius, Katharina Kerschan-Schindl, Michael Uder i Wolfgang Kemmler. "Effekt von additivem körperlichem Training zur Bisphosphonat-Therapie auf die Knochendichte: Eine systematische Übersichtsarbeit und Meta-Analyse". Osteologie 31, nr 03 (sierpień 2022): 184–94. http://dx.doi.org/10.1055/a-1904-5706.
Pełny tekst źródłaStepaniuk, Kevin. "Bisphosphonate Related Osteonecrosis of the Jaws: A Review". Journal of Veterinary Dentistry 28, nr 4 (grudzień 2011): 277–81. http://dx.doi.org/10.1177/089875641102800413.
Pełny tekst źródłaThirunavukarasu, Ananthi, Hugo Grancho Pinto i Kevin Guy Seymour. "Bisphosphonate and Implant Dentistry – is it Safe?" Primary Dental Journal 4, nr 3 (wrzesień 2015): 30–33. http://dx.doi.org/10.1308/205016815815944650.
Pełny tekst źródłaKawai, Toshiyuki, Kohei Nishitani, Yaichiro Okuzu, Koji Goto, Yutaka Kuroda, Shinichi Kuriyama, Shinichiro Nakamura i Shuichi Matsuda. "Bisphosphonate use is associated with a decreased joint narrowing rate in the non-arthritic hip". Bone & Joint Research 11, nr 11 (1.11.2022): 826–34. http://dx.doi.org/10.1302/2046-3758.1111.bjr-2022-0155.r1.
Pełny tekst źródłaBourrion, Bastien, Cécile Souty, Lucie Fournier, Ana-Maria Vilcu, Thierry Blanchon, Pierre-Yves Böelle, Thomas Hanslik i Mathilde François. "Bisphosphonate Use and Hospitalization for Hip Fractures in Women: An Observational Population-Based Study in France". International Journal of Environmental Research and Public Health 18, nr 16 (20.08.2021): 8780. http://dx.doi.org/10.3390/ijerph18168780.
Pełny tekst źródłaLloyd, Ashley A., Bernd Gludovatz, Christoph Riedel, Emma A. Luengo, Rehan Saiyed, Eric Marty, Dean G. Lorich i in. "Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance". Proceedings of the National Academy of Sciences 114, nr 33 (31.07.2017): 8722–27. http://dx.doi.org/10.1073/pnas.1704460114.
Pełny tekst źródłaNtep, Ntep David Bienvenue, Ernest Kenna, Siafa Antoine Bola i Messanga Charles Bengondo. "The Potential Role of Angiogenic Osteoclast Inhibition in the Occurrence of Bisphosphonate-related Osteonecrosis of the Jaw". Case Reports in Dental Science 1, nr 1 (30.06.2020): 15–21. http://dx.doi.org/10.46619/crds.2020.1-1004.
Pełny tekst źródłaSawatari, Yoh, i Robert E. Marx. "Bisphosphonates and Bisphosphonate Induced Osteonecrosis". Oral and Maxillofacial Surgery Clinics of North America 19, nr 4 (listopad 2007): 487–98. http://dx.doi.org/10.1016/j.coms.2007.07.003.
Pełny tekst źródłaRozprawy doktorskie na temat "Bisphosphonate"
Roelofs, Anke. "Anti-tumour mechanisms of action bisphosphonates and bisphosphonate analogues". Thesis, University of Oxford, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.436994.
Pełny tekst źródłaDebbabi, M., M. Othmani i A. Aissa. "Nanocrystalline Hydroxyapatite-Bisphosphonate Composites". Thesis, Sumy State University, 2013. http://essuir.sumdu.edu.ua/handle/123456789/35199.
Pełny tekst źródłaSharma, Chakrabhavi Gundurao Dileep. "Role of Inflammation and Angiogenesis in Aetiology of Bisphosphonate-related Osteonecrosis of the Jaws". Thesis, Griffith University, 2016. http://hdl.handle.net/10072/367505.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Dentistry and Oral health
Griffith Health
Full Text
Duan, Ke. "Bisphosphonate-containing coatings for bone implants". Thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/31288.
Pełny tekst źródłaApplied Science, Faculty of
Materials Engineering, Department of
Graduate
Stewart, Charlotte. "Structure activity relationships of bisphosphonate analogues". Thesis, University of Aberdeen, 2010. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=128207.
Pełny tekst źródłaBenford, Helena L. "Molecular pathways of bisphosphonate-induced apoptosis". Thesis, University of Aberdeen, 2000. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU602025.
Pełny tekst źródłaWhite, Courtney Ellen. "Characteristics of bisphosphonate elution from orthopaedic implants". Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=99121.
Pełny tekst źródłaDuan, Xuchen. "Physiological and biological mechanisms of bisphosphonate action". Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:36b0439d-2f89-4c1e-8bb3-941b4e6ee847.
Pełny tekst źródłaRoberts, Jacintha. "Studies on bisphosphonate elution from orthopaedic implants". Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=112582.
Pełny tekst źródłaPhoebe, Erin, Jeff Pasteur, Marion Slack i Jeannie Lee. "Fracture Risk with Bisphosphonate Use versus Concurrent Proton Pump Inhibitor and Bisphosphonate Use: A Systematic Review and Meta- Analysis". The University of Arizona, 2013. http://hdl.handle.net/10150/614271.
Pełny tekst źródłaSpecific Aims: To determine whether concurrent use of a proton pump inhibitor (PPI) and a bisphosphonate represent an additional fracture risk compared with bisphosphonate use alone and to identify an increased risk of any particular fracture type. Methods: This study was a systematic review and meta-analysis of data collected from PubMed, Cochrane, OVID Medline, Google Scholar, and IPA. The authors utilized the search terms: bisphosphonate, fractures and proton pump inhibitors. Studies which met criteria of being English-language with adults 18 years of age and older were included. Main Results: The studies were cohort studies and primarily evaluated older adults. The summary effect was that use of a PPI with a bisphosphonate showed a slight increase in fracture risk when compared to bisphosphonate-only therapy (odds ratio [OR] 1.12, 95% confidence interval [CI], 1.06-1.18). Systematic review of similar studies showed varied results, making difficult any conclusion regarding fracture risk among the treatments. Conclusion: In this analysis, PPI + bisphosphonate demonstrated a slight increase in fracture rate without inference to an increase in any particular fracture type compared with bisphosphonate only. However, there is minimal data on the association or causal effect of this increase. The few studies available offered contradictory results. Additionally, database studies are subject to the possibility of residual confounding. Further research using randomized control trial (RCT) design evaluating long term use of bisphosphonates with or without PPI and their impact on fractures is needed to determine if there is an additional degree of fracture risk from the concurrent use.
Książki na temat "Bisphosphonate"
Maria, Bijvoet Olav Leonardus, red. Bisphosphonate on bones. Amsterdam: Elsevier, 1995.
Znajdź pełny tekst źródłaGirard, Bruno. Exploring high dose effects of a bisphosphonate (HEBP) on osteogenesis in vitro. [Toronto: Faculty of Dentistry, University of Toronto], 2000.
Znajdź pełny tekst źródłaCatherine, Allison, i Canadian Coordinating Office for Health Technology Assessment., red. An assessment of bisphosphonate drugs to manage pain secondary to bone metastases. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2004.
Znajdź pełny tekst źródłaMarx, Robert E. Oral & intravenous bisphosphonate-induced osteonecrosis of the jaws: History, etiology, prevention, and treatment. Chicago: Quintessence Pub. Co., 2006.
Znajdź pełny tekst źródłaRebecca, Wong, i Canadian Coordinating Office for Health Technology Assessment., red. Bisphosphonate agents for the management of pain secondary to bone metastases: A systematic review of effectiveness and safety. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2004.
Znajdź pełny tekst źródłaOral and intravenous bisphosphonate-induced osteonecrosis of the jaws: History, etiology, prevention, and treatment. Wyd. 2. Chicago: Quintessence Pub. Co., Inc., 2011.
Znajdź pełny tekst źródłaPonte, Francesco Saverio De. Bisphosphonates and osteonecrosis of the jaw: A multidisciplinary approach. Milan: Springer, 2012.
Znajdź pełny tekst źródłaChan, Cary Chung-Keung. Effects of cyclical parathyroid hormone (1-34) fragments and (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate treatment on bone in ovariectomized rats. Ottawa: National Library of Canada, 1994.
Znajdź pełny tekst źródłaBartl, Reiner, Emmo von Tresckow i Christoph Bartl. Bisphosphonat-Manual. Berlin, Heidelberg: Springer Berlin Heidelberg, 2006. http://dx.doi.org/10.1007/3-540-31271-4.
Pełny tekst źródłaBrunner, Kurt W., Herbert Fleisch i Hans-Jörg Senn, red. Bisphosphonates and Tumor Osteolysis. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83668-8.
Pełny tekst źródłaCzęści książek na temat "Bisphosphonate"
Ruth, Todd H., i Veena Graff. "Bisphosphonate Infusion Therapy". W Infusion Therapy, 107–13. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17478-1_8.
Pełny tekst źródłaBartl, Reiner. "Bisphosphonate und Denosumab". W Osteoporose in der Praxis, 117–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2022. http://dx.doi.org/10.1007/978-3-662-64207-8_10.
Pełny tekst źródłaBartl, Reiner. "Bisphosphonate und Denosumab". W essentials, 31–44. Berlin, Heidelberg: Springer Berlin Heidelberg, 2022. http://dx.doi.org/10.1007/978-3-662-65475-0_5.
Pełny tekst źródłaBartl, Reiner, i Christoph Bartl. "Bisphosphonate und Denosumab". W Das Osteoporose Manual, 205–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 2021. http://dx.doi.org/10.1007/978-3-662-62528-6_20.
Pełny tekst źródłaReszka, Alfred A. "Bisphosphonate Mechanisms of Action". W Osteoporosis, 443–68. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-459-9_19.
Pełny tekst źródłaWatts, Nelson B. "Bisphosphonate Therapy for Osteoporosis". W Atlas of Osteoporosis, 189–94. London: Current Medicine Group, 2003. http://dx.doi.org/10.1007/978-1-4757-4561-0_16.
Pełny tekst źródłaBone, Henry. "Bisphosphonate Therapy for Postmenopausal Osteoporosis". W Osteoporosis in Clinical Practice, 133–42. London: Springer London, 2004. http://dx.doi.org/10.1007/978-0-85729-402-9_17.
Pełny tekst źródłaMawardi, Hani H., Nathaniel S. Treister i Sook-Bin Woo. "Bisphosphonate-Associated Osteonecrosis of the Jaws". W Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 929–40. Ames, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118453926.ch112.
Pełny tekst źródłaZavras, Athanasios. "Bisphosphonate Related Osteonecrosis of the Jaw". W Genomics, Personalized Medicine and Oral Disease, 311–31. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17942-1_14.
Pełny tekst źródłaCairoli, Elisa, i Iacopo Chiodini. "Biomarkers of Bisphosphonate Failure in Osteoporosis". W Biomarkers in Bone Disease, 1065–85. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-007-7693-7_45.
Pełny tekst źródłaStreszczenia konferencji na temat "Bisphosphonate"
Kozloff, Kenneth M., Leo I. Volakis, Joan C. Marini i Michelle S. Caird. "Near-Infrared Imaging Reveals Site- and Age-Specific Localization of Bisphosphonate Delivery and Retention in Model of Osteogenesis Imperfecta". W ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-205344.
Pełny tekst źródłaGnant, M. "Abstract PL02: Adjuvant bisphosphonate therapy in breast cancer". W Abstracts: Thirty-Sixth Annual CTRC-AACR San Antonio Breast Cancer Symposium - Dec 10-14, 2013; San Antonio, TX. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/0008-5472.sabcs13-pl02.
Pełny tekst źródłaZhou, Yilu, Lauren Resutek, Liyun Wang i X. Lucas Lu. "Effects of Bisphosphonate on Long-Term Culture of Cartilage Allografts". W ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14635.
Pełny tekst źródłaRudnick-Glick, S., E. Corem-Salkmon, I. Grinberg, E. Gluz i S. Margel. "Biodegradable bisphosphonate nanoparticles for imaging and therapeutic applications in osteosarcoma". W SPIE Nanoscience + Engineering, redaktorzy Hooman Mohseni, Massoud H. Agahi i Manijeh Razeghi. SPIE, 2015. http://dx.doi.org/10.1117/12.2186765.
Pełny tekst źródłaPapineni, Rao V., Thirupandiyur Udayakumar, Mansoor Ahmed, John Pizzonia i Alan Pollack. "Abstract 5327: In vivo fluorescence imaging of solid tumor-bisphosphonate interaction". W Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-5327.
Pełny tekst źródłaRydzik, Anna, Joanna Zuberek, Joanna Kowalska, Edward Darżynkiewicz i Jacek Jemielity. "Bisphosphonate modification in tetraphosphate 5'mRNA cap analogs – synthesis and biochemical properties". W XIVth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2008. http://dx.doi.org/10.1135/css200810444.
Pełny tekst źródłaNewton, Kathe`rine, Ruth Keeble i Nikki Reed. "P-204 Bisphosphonate treatment in bone metastases: an interventional outpatient clinic model". W People, Partnerships and Potential, 16 – 18 November 2016, Liverpool. British Medical Journal Publishing Group, 2016. http://dx.doi.org/10.1136/bmjspcare-2016-001245.225.
Pełny tekst źródłasohrabi, Beheshteh, i Sara Mashkoori. "The theoretical study of bisphosphonate derivatives as drug for inhibition of cancer". W The 14th International Electronic Conference on Synthetic Organic Chemistry. Basel, Switzerland: MDPI, 2010. http://dx.doi.org/10.3390/ecsoc-14-00388.
Pełny tekst źródłaYutani, Y., i Y. Yamano. "SAT0056 Bisphosphonate modulates ectopic bone formation after hip arthroplasty -with japanese cases-". W Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.431.
Pełny tekst źródłaSantos, Miguel, Sónia Teixeira, Maria Fernandes, João Rodrigues i Luís Branco. "Antitumor and osteogenic activity of bisphosphonate-based organic salts and ionic liquids". W 6th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/ecmc2020-07924.
Pełny tekst źródłaRaporty organizacyjne na temat "Bisphosphonate"
Chen, Po-Wei, Hsiao-Yuan Su, Chih-Hsing Wu, Jih-I. Yeh, Ching-Hui Loh, Li-Yu Chen, Huei-Kai Huang i Shu-Man Lin. Association of Bisphosphonates with Risk of Incident Diabetes and Glycemic Control: A Protocol of Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2022. http://dx.doi.org/10.37766/inplasy2022.4.0125.
Pełny tekst źródłaPalmer, Matthew R. Bisphosphonate-Based Contrast Agents for Radiological Imaging of Microcalcifications. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2004. http://dx.doi.org/10.21236/ada431695.
Pełny tekst źródłaPalmer, Matthew R. Bisphosphonate-Based Contrast Agents for Radiological Imaging of Microcalcifications. Fort Belvoir, VA: Defense Technical Information Center, marzec 2006. http://dx.doi.org/10.21236/ada468525.
Pełny tekst źródłaDioguardi, Mario. Post-Extraction Complications in Patients Undergoing Oral Bisphosphonate Therapy. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2022. http://dx.doi.org/10.37766/inplasy2022.11.0035.
Pełny tekst źródłaSelander, Katri. Toll-Like Receptor Pathway as Mediator of Bisphosphonate Effects in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2005. http://dx.doi.org/10.21236/ada439205.
Pełny tekst źródłaPrice, Chrisopher. Bisphosphonates in the Prevention of Post-Traumatic Osteoarthritis. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2014. http://dx.doi.org/10.21236/ada615280.
Pełny tekst źródłaXiang, Kemeng, Huiming Hou i Ming Zhou. The efficacy of Cerus and Cucumis Polypeptide injection combined with Bisphosphonates on postmenopausal women with osteoporosis:A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0067.
Pełny tekst źródłaHuang, Huei-Kai, Shu-Man Lin, Carol Chiung-Hui Peng, Kashif M. Munir, Khulood Bukhari, Kory Jaggon i Yunting Fu. Bisphosphonates and the risk of stroke: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2022. http://dx.doi.org/10.37766/inplasy2022.3.0085.
Pełny tekst źródłaKHANOV, A. G., L. I. Datchina i S. S. Brovkina. DO WE NEED A BREAKTHROUGH IN OSTEOPOROSIS AND HOW TO ORGANIZE IT (THE PHARMACOLOGICAL JUSTIFICATION IN PREMEDICATION FOR INTRAVENOUS BISPHOSPHONATES). "PLANET", 2019. http://dx.doi.org/10.18411/978-5-907192-54-6-2019-xxxvi-174-186.
Pełny tekst źródłaWu, Yao, Fangyong Wang i Zhenrong Zhang. Efficacy and Safety of Bisphosphonates Analogues in Persons with Osteoporosis after Spinal Cord Injury: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2020. http://dx.doi.org/10.37766/inplasy2020.7.0013.
Pełny tekst źródła